2,4-thiazolidinedione has been researched along with HIV Coinfection in 3 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Type 2 diabetes is increasingly common in HIV-infected individuals." | 1.46 | Comparative Effectiveness of Diabetic Oral Medications Among HIV-Infected and HIV-Uninfected Veterans. ( Bisson, GP; Gibert, CL; Gordon, K; Han, JH; Leaf, DA; Rimland, D; Rodriguez-Barradas, MC; Womack, JA, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, JH | 1 |
| Gordon, K | 1 |
| Womack, JA | 1 |
| Gibert, CL | 1 |
| Leaf, DA | 1 |
| Rimland, D | 1 |
| Rodriguez-Barradas, MC | 1 |
| Bisson, GP | 1 |
| Carrillo-Jimenez, R | 1 |
| Lamas, GA | 1 |
| Hennekens, CH | 1 |
| Currier, JS | 1 |
1 review available for 2,4-thiazolidinedione and HIV Coinfection
| Article | Year |
|---|---|
Thiazolidinediones could improve endothelial dysfunction and risk of premature coronary heart disease in HIV-infected patients.
Topics: Animals; Coronary Disease; Endothelium, Vascular; HIV Infections; Humans; Patients; Risk Factors; Th | 2002 |
2 other studies available for 2,4-thiazolidinedione and HIV Coinfection
| Article | Year |
|---|---|
Comparative Effectiveness of Diabetic Oral Medications Among HIV-Infected and HIV-Uninfected Veterans.
Topics: Adult; Black or African American; Blood Glucose; Body Mass Index; Comparative Effectiveness Research | 2017 |
How to manage metabolic complications of HIV therapy: what to do while we wait for answers.
Topics: Anabolic Agents; Anti-HIV Agents; Anticholesteremic Agents; Atorvastatin; Exercise Therapy; Gemfibro | 2000 |